Subscribe

0

  • Sign in with Email

By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.

Don’t have an account? Signup

  • Bookmarks
  • My Profile
  • Log Out
  • NEWS
  • POLICIES
  • MSME OPPORTUNITIES
  • BANKING & FINANCE
  • TECHNOLOGY FOR SMES
  • SECTORS
  • GLOBAL
  • Investment
  • LEGAL
  • KNOWLEDGE QUEST
  • Future Ready Forum 2025
  • Ek Nayi Udaan
  • Future Ready Summit 2024
  • ADVERTISE WITH US
ad_close_btn
  • News
  • Policies
  • Banking & Finance
  • MSME Opportunities
  • Web Stories
  • InFocus
  • Technology For SMEs
  • Sectors
  • Global
  • Fashion

Powered by :

You have successfully subscribed the newsletter.

COVID 19 Coronavirus

Favipiravir, COVID 19 Coronavirus News

Price War in Favipiravir Space to Combat COVID-19

Initially, it was Glenmark Pharma which launched the drug for Rs 103 per tablet in June, it revised the price recently to Rs 79 a tablet. This was followed by Pune's Brinton Pharma got a nod for the tablets this week and they have chosen to price it for Rs 59 per tablet. But the latest news in this direction is an entry of another Mumbai based company Jenburkt Pharma wich has launched Favipiravir under a brand name of Favivent for Rs 39 per tablet.

By SMEStreet Desk
logoJul 26, 2020 06:54 IST logo 2 Min read
newsletter image
Subscribe to our Newsletter! Be the first to get exclusive offers and the latest news
Latest Stories
Subscribe to our Newsletter! Be the first to get exclusive offers and the latest news

Latest Stories
Latest Stories
    Powered by


    Subscribe to our Newsletter!




    Powered by
    Select Language
    English

    Share this article

    If you liked this article share it with your friends.
    they will thank you later

    Facebook
    Twitter
    Whatsapp

    Copied!